Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-26

FDA Approved: DAPTOMYCIN — Original Application (BE Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved BE Pharmaceuticals Inc.'s original application for daptomycin, enabling the generic version of this antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daptomycin (daptomycin)

Snippet

ORIG AP for DAPTOMYCIN (DAPTOMYCIN)